Ferrer-Font, L., Villamañan, L., Arias-Ramos, N., Vilardell, J., Plana, M., Ruzzene, M., . . . Candiota, A. P. (2017). Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice. Pharmaceuticals (Basel).
Styl ChicagoFerrer-Font, Laura, et al. "Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice." Pharmaceuticals (Basel) 2017.
Citace podle MLAFerrer-Font, Laura, et al. "Targeting Protein Kinase CK2: Evaluating CX-4945 Potential for GL261 Glioblastoma Therapy in Immunocompetent Mice." Pharmaceuticals (Basel) 2017.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..